What class is Luvox (fluvoxamine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Luvox Drug Classification

Luvox (fluvoxamine) is a selective serotonin reuptake inhibitor (SSRI). 1, 2

Mechanism of Action

  • Fluvoxamine facilitates serotonergic neurotransmission through potent and selective inhibition of serotonin (5-HT) reuptake into presynaptic neurons. 3
  • The drug is chemically unrelated to other SSRIs and clomipramine, belonging to the 2-aminoethyl oxime ethers of aralkylketones chemical series. 2
  • Fluvoxamine has little or no effect on other monoamine reuptake mechanisms, distinguishing it from non-selective agents. 4

FDA-Approved Indications

  • Fluvoxamine is FDA-approved for the treatment of obsessive-compulsive disorder (OCD). 1
  • The drug was the first SSRI registered for treatment of OCD in children and adolescents. 5

Pharmacological Profile

Cytochrome P450 Interactions

  • Fluvoxamine has substantial pharmacological interactions due to its effects on multiple cytochrome P450 enzymes. 6
  • It is a weak inhibitor of CYP2D6, a moderate inhibitor of CYP2C19 and CYP3A4, and a potent inhibitor of CYP1A2. 4, 6
  • This interaction profile differs from other SSRIs, with fluvoxamine having less effect on CYP2D6 compared to agents like fluoxetine or paroxetine. 4

Receptor Affinity

  • Fluvoxamine demonstrates poor affinity for adrenergic, muscarinic, cholinergic, or histaminergic receptors, contributing to its favorable tolerability profile. 7
  • Among SSRIs, fluvoxamine has the highest affinity for Sigma-1 receptors, which modulate cytokine levels and may have anti-inflammatory properties. 1

Common Pitfalls

  • Do not confuse fluvoxamine's SSRI classification with its unique pharmacokinetic profile—its potent CYP1A2 inhibition creates different drug-drug interactions compared to other SSRIs like sertraline or citalopram. 6, 4
  • Fluvoxamine's substantial pharmacological interactions require careful consideration when prescribing with other medications, particularly those metabolized by CYP1A2. 6
  • The drug's high affinity for Sigma-1 receptors distinguishes it mechanistically from other SSRIs, though this does not change its primary classification. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.